🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, phase I study of combination therapy with...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-09
Trial ID
NCT01434069
Treatments Being Tested
This is a monocenter, single-arm, open label phase II trial evaluating the ...
Status
Completed
Location
Klinik und Poliklinik für Neurologie der Universität Regensburg
Start Date
2012-03
Trial ID
NCT02021942
Treatments Being Tested
The purpose of the current study is to evaluate the efficacy and safety of ...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2025-05-30
Trial ID
NCT06784752
Treatments Being Tested
Observe the safety/tolerability and effectiveness in terms of response rate...
Status
Withdrawn
Location
Penn State Milton S. Hershey Medical Center
Start Date
2010-12
Trial ID
NCT01234974
Treatments Being Tested
After failure of initial ADT, addition of an anti-androgen is established t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-08
Trial ID
NCT01646684
Treatments Being Tested
This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Status
Completed
Location
University of Michigan
Start Date
2010-07-19
Trial ID
NCT01137682
Treatments Being Tested
The purpose of this study is to allow continued use of pasireotide in patie...
Status
Completed
Location
Ximed Research SC - SOM230B2412
Start Date
2013-06-10
Trial ID
NCT01794793
Treatments Being Tested
This study will evaluate long-term safety and tolerability of pasireotide L...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05-18
Trial ID
NCT01590199
This study will assess the pharmacokinetic profile and the safety/tolerabil...
Status
Completed
Location
Cedars Sinai Medical Center SC - 4
Start Date
2006-06
Trial ID
NCT00446082
Treatments Being Tested
This study will estimate the treatment effect of everolimus in combination ...
Status
Terminated
Location
Dana Farber Cancer Institute SC-2
Start Date
2011-06
Trial ID
NCT01374451
Treatments Being Tested